Cargando…
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
One of the challenging issues in vaccine development is peptide and adjuvant delivery into target cells. In this study, we developed a vaccine and therapeutic delivery system to increase cytotoxic T lymphocyte (CTL) response against a breast cancer model overexpressing HER2/neu. Gp2, a HER2/neu-deri...
Autores principales: | Razazan, Atefeh, Behravan, Javad, Arab, Atefeh, Barati, Nastaran, Arabi, Leila, Gholizadeh, Zahra, Hatamipour, Mahdi, Reza Nikpoor, Amin, Momtazi-Borojeni, Amir Abbas, Mosaffa, Fatemeh, Ghahremani, Mohamad Hosein, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646774/ https://www.ncbi.nlm.nih.gov/pubmed/29045460 http://dx.doi.org/10.1371/journal.pone.0185099 |
Ejemplares similares
-
Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice
por: Razazan, Atefeh, et al.
Publicado: (2019) -
Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer
por: Naghibi, Laleh, et al.
Publicado: (2020) -
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019) -
PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021) -
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2023)